Each health care provider shall use a validated and evidence based verbal screening tool to assess a substance use disorder in pregnancy for all pregnant women who are seen by the health care provider:

1. (1) as early as possible at the onset of prenatal care; and
2. (2) throughout the pregnancy, including during the first, second, and third trimester.

As added by P.L.292-2019, SEC.2.